Pfizer 2014 Annual Report Download - page 62

Download and view the complete annual report

Please find page 62 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 62
ANNUAL REVIEW 2014
ACCESS TO MEDICINES
Our World > Access to Medicines
Healthy Connections
A joint effort by Pro Mujer, Mayo Clinic, Sesame Workshop and
Pzer, Healthy Connections promotes non-communicable disease
prevention and family health among women and children in
numerous countries across Latin America. Healthy Connections will
use a new technology platform integrating mobile, web and video
technology, along with remote training and access to specialists.
WIPO Re:Search
An R&D consortium dedicated to developing new solutions —
including medicines, vaccines and diagnostics — for neglected
tropical diseases, malaria and tuberculosis, WIPO Re:Search
was created in partnership with the World Intellectual Property
Organization (WIPO), BIO Ventures for Global Health and other
leaders in the R&D pharmaceutical industry. The consortium has
over 90 members from 26 countries, has 85 collaborations/research
agreements in place, and has facilitated eight arrangements
whereby scientists from both developed and developing countries
are hosted by members of WIPO Re:Search. Pzer is involved in
several agreements where we are making specic contributions to
advance external research programs targeting diarrhea, dengue
fever and cerebral malaria.
GLOBAL PARTNERSHIPS TO EXPAND ACCESS
Pzer helps expand access worldwide by working in partnership with
non-governmental organizations, government agencies, multilateral
aid organizations and other global health stakeholders to strengthen
health care systems and improve care. Our investments also include
programs that provide direct assistance, such as product donations
and steep discounts, to help bridge current gaps in health care
delivery to various underserved populations.
International Trachoma Initiative (ITI)
A global program Pzer helped to found, ITI has been working since
1998 to eliminate blinding trachoma as a public health concern.
Through the ITI, we have donated more than 400 million doses
of the antibiotic Zithromax® (azithromycin) to prevent and treat
trachoma in support of the World Health Organization-led Global
Alliance for the Elimination of Trachoma by the year 2020.
Diflucan Partnership
Through this partnership, Pzer provides, free of charge to
government and non-governmental organizations in developing
countries, Diucan® (uconazole) for the treatment of two
fungal opportunistic infections associated with HIV and AIDS —
cryptococcal meningitis and esophageal candidiasis. Since the
launch of the program in 2000, Pzer has donated over $1.4 billion
in medicine to more than 6,000 sites in 63 countries in Africa, Asia,
the Caribbean and Latin America. Fifteen years into the program,
Pzer has clearly demonstrated its commitment to addressing public
health issues in the developing world by helping improve the quality
of life of people living with HIV and AIDS.